PrEP delivery and routine care provide a unique opportunity to promote sexually transmitted
infection (STI) prevention by both increasing STI testing frequency and creating a space for …

Background: In the iPrEx Open Label Extension (OLE) study counselors integrated Next
Step Counseling (NSC-developed by iPrEx to promote adherence) with sexual health …

One dramatic advance in human immunodeficiency virus (HIV) prevention efforts has been
the prescription of medications typically used for HIV treatment as prophylaxis against …

Pre-exposure prophylaxis (PrEP) is a biomedical HIV prevention intervention approved by
the FDA in 2012. Nevertheless, most sexual minority men (SMM) who could benefit from its …

Pre-exposure prophylaxis (PrEP) is a safe and effective HIV prevention strategy. Given the
possibility of increased sexual risk-taking and acquisition of other sexually transmitted …

Pre-exposure prophylaxis (PrEP) is a highly effective HIV prevention option for gay, bisexual
and other men who have sex with men (GBMSM). However, with newer PrEP options, a …

Although pre-exposure prophylaxis (PrEP) use is increasing among men who have sex with
men (MSM), condoms remain key to HIV prevention. Implementation intentions—which link …

Despite considerable discussion and debate about adherence to preexposure prophylaxis
(PrEP) for human immunodeficiency virus (HIV), scant data are available that characterize …

Background: The aim of this study was to evaluate the efficacy of a novel, brief 2-session
behavioral intervention to promote HIV pre-exposure prophylaxis (PrEP) uptake among men …

Existing trials of antiretroviral (ARV) medication as chemoprophylaxis against HIV reveal that
the degree of protection is primarily dependent on product adherence. However, there is a …